Key result
Elevated levels of pro-inflammatory cytokines IL-6 and TNF-alpha were significantly associated with the presence, severity, and 2-year mortality (17.2%) of congestive heart failure.
Case-Control (n=366)
Pro-inflammatory cytokines IL-6 and TNF-alpha are elevated in chronic heart failure and correlate with disease severity, ischemic etiology, and worse prognosis.
Supports prognostic role of IL-6 and TNF-alpha in HF; leaves open whether cytokine inhibition improves survival.
INTRODUCTION: Recent evidence shows that pro-inflammatory cytokines may be important in the assessment of severity and prognosis in congestive heart failure (CHF). In the present study, we examine the association of cytokines with causes, grade and prognosis of CHF patients. SUBJECTS AND METHODS: Of 127 patients with CHF, 11 were excluded and the remaining 116 patients with different aetiologies of CHF, and 250 age- and sex-matched control subjects, were evaluated in this case study. Severity of disease based on the New York Heart Association (NYHA) standards, fell within functional classes II to IV. The diagnosis of HF was based on clinical manifestations as well as on echocardiographic heart enlargement. Cytokines were measured by chemiluminescence. Causes of death were assessed based on death certificates. Multivariate logistic regression analysis was used to determine the risk factors of heart failure. RESULTS: Echocardiographic ejection fraction was 39.1 +/- 8.2% (mean +/- SD) in the study group indicating class II-IV heart failure. Laboratory data showed increase in biomarkers of oxidative stress, among HF patients compared to healthy subjects. Pro-inflammatory cytokines; IL-6 and TNF-alpha were significantly higher among HF patients compared to healthy subjects. TNF-alpha and IL-6, showed significant increase among patients with CHF due to ischaemic heart disease and cardiomyopathy compared to levels among CHF patients with valvular heart disease and hypertensive heart diseases. The levels of the cytokines were significantly higher among patients with class III and IV heart failure and those who died, compared to patients with class II heart failure. Multivariate logistic regression analysis revealed that CAD, cardiomyopathy, and IL-6 were strongly associated--and low ejection fraction and TNF-alpha--weakly associated with HF. Of 116 patients, 20 (17.2%) died during a follow-up of two years, and the deaths were mainly among NYHA class III and IV patients in whom the cause of CHF was CAD (10.9%) and cardiomyopathy (6.9%) which had greater levels of cytokines. CONCLUSIONS: The findings indicated that pro-inflammatory cytokines may be important indicators of causes, severity of CHF and prognosis among these patients.
No takes yet. Share an insight, caveat, or question.
Fedačko et al. (2014) conducted a case-control in Congestive heart failure (n=366). Pro-inflammatory cytokines (IL-6 and TNF-alpha) vs. Healthy subjects was evaluated on Heart failure and 2-year mortality. Elevated levels of pro-inflammatory cytokines IL-6 and TNF-alpha were significantly associated with the presence, severity, and 2-year mortality (17.2%) of congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: